As for every dreadful diseases and ailments, once diagnosis and necessary tests confirm and show anyone is infected with any of the known deadly and dreadful diseases, he or she would immediately seek to know and be told his or her chances of survival for a particular or specific period of time like 5years to 10 years and based on the stage of the disease when diagnosed. This is known as Survival Rate. Survival Rate is the determining factor that shows how long a group of people with the same stage of the same disease will survive from the time of diagnosis. In the world today, one of the deadliest diseases or ailment is Cancer. Cancer is famously known to affect several parts of the human body to cause cancer like Breast cancer, skin cancer, and kidney cancer, cancer of the cervix, lung cancer, ovarian cancer and lots more. Survival rates are gotten from statistical data of people having the same ailment at the same stage when diagnosed and how many years they lived after they have been confirmed and diagnosed of such disease. They average years lived for each of the people in that stage results into the survival rate. In this article, I will be discussing the survival rate of Melanoma skin cancer.
Statistics data for a certain type and stage of cancer are often given as 5-year or 10-year survival rates, but many people live longer – often much longer. The survival rate is the percentage of people who live at least a certain amount of time after being diagnosed with cancer.
For example, a 5-year survival rate of 75% means that an estimated 75 out of 100 people who have that cancer are still alive 5 years after being diagnosed. Keep in mind, however, that many of these people live much longer than 5 years after diagnosis.
It is crucial to say that survival rate is based on previous data collected and analyzed and this might not be the case for you because they are estimates. This is so because medical breakthrough over some ailment may increase survival rate of some people than what has been previously recorded.
Survival rates for melanoma skin cancer
The following survival rates are based on nearly 60,000 patients who were part of the 2008 AJCC Melanoma Staging Database. These survival rates include some people diagnosed with melanoma who may have died later from other causes or infection. Therefore, the percentage of people surviving the melanoma itself may be higher.
Stage IA: The 5-year survival rate is around 97%. The 10-year survival is around 95%.
Stage IB: The 5-year survival rate is around 92%. The 10-year survival is around 86%.
Stage IIA: The 5-year survival rate is around 81%. The 10-year survival is around 67%.
Stage IIB: The 5-year survival rate is around 70%. The 10-year survival is around 57%.
Stage IIC: The 5-year survival rate is around 53%. The 10-year survival is around 40%.
Stage IIIA: The 5-year survival rate is around 78%. The 10-year survival is around 68%.*
Stage IIIB: The 5-year survival rate is around 59%. The 10-year survival is around 43%.
Stage IIIC: The 5-year survival rate is around 40%. The 10-year survival is around 24%.
Stage IV: The 5-year survival rate is about 15% to 20%. The 10-year survival is about 10% to 15%. The outlook is better if the spread is only to distant parts of the skin or distant lymph nodes rather than to other organs, and if the blood level of lactate dehydrogenase (LDH) is normal.
*The survival rate is higher for stage IIIA cancers than for some stage II cancers. This is likely because the main (primary) tumor is often less advanced for IIIA cancers, although this is not clear.
Remember, these survival rates are only estimates – they can’t predict what will happen to any individual. We understand that these statistics can be confusing and might lead you to have more questions. Talk to your doctor to better understand your specific situation.
However, other factors affect survival rate of some people and these factors include:
- Older people mostly have shorter survival times than younger people, regardless of stage.
- Melanoma is uncommon among African Americans, when it occurs rarely, survival time is shorter when compared to whites.
- People with melanoma and a feeble and weak immune systems from organ transplants or people with HIV will also have shorter survival time.